The Opioid-Exposed Woman

Size: px
Start display at page:

Download "The Opioid-Exposed Woman"

Transcription

1 The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus with labor management implications. Explain rationale for opioid-assisted therapy for pregnant women who are challenged with opioid addiction. Discuss pain management strategies for mothers who may be dependent on opioids. 1

2 Risks to Woman Third trimester bleeding Poor antenatal nutrition Concurrent abuse of other substances IV use related complications: cellulitis, endocarditis, chorioamnionitis, bloodborne disease (HIV) Concurrent sexually transmitted infection Hepatitis C Social: prostitution, violence, incarceration, loss of custody Risks to Fetus/Newborn Intrauterine growth restriction Preterm birth Transmission of maternal infection Malpresentation Meconium Decreased APGAR Acute opioid withdrawal: HTN, tachycardia, preterm birth, abruption, meconium aspiration, abnormal FHR patterns Neonatal abstinence syndrome Additional Barriers to Pregnancy Health Lack prenatal care or late presentation shame fear of stigmatization fear of pressure to enroll in a treatment program Limited social support: many come from multigenerational drug abusing families Lack of positive parenting role models Psychiatric illness 56-73% Past trauma/sexual abuse 39% History of participation in sex trafficking 32% (Source: McKeever, et al. 2014) 2

3 Comprehensive Care Opioid-assisted therapy (generally preferable to withdrawal) Social Housing Employment Parenting more likely to lack role model or social support in family Intimate partner violence Legal needs Chemical dependency counseling Family therapy Nutritional education/monitor weight Behavioral health Home visits/community health nurse Why Treat With Opioids? Withdrawal risk to fetus: Preterm labor Fetal distress/fetal demise Prevent complications associated with illicit use Increased consistency of prenatal care Opportunity to encourage treatment Reduce criminal activity Less risk to patient from association with drug culture Reduced risk of obstetric complications Methadone Standard treatment for heroin addiction and recently for other opioids Requires daily dispensing from a federally authorized treatment program Blocks euphoria from other opioids Dosage adjusted to avoid withdrawal symptoms metabolism may change with pregnancy Inadequate dose harmful to fetus and increases potential for illicit use 3

4 Buprenorphine Can be prescribed in office setting by specifically credentialed physicians Lack of evidence from long term neurodevelopmental studies Available as single agent (Subutex-advised for pregnancy) or in combination with naloxone (Suboxone) Minimizes withdrawal symptoms and blocks effects of illicit opioids Self-administered Risk of diversion with single agent Lower risk of overdose Fewer drug interactions Less severe neonatal abstinence Labor Care Potential increased anxiety and more pain especially if sexual trauma history No difference in intrapartum pain perception noted by Meyer and colleagues (2007) No reason to suspect drug-seeking in stable mom Should not be denied adequate pain management maintenance opioids not adequate Non-pharmacologic measures should be included Nitrous? Notify pediatric provider Medical Pain Management in Labor Avoid narcotic agonist-antagonist drugs due to risk of acute withdrawal (butorphanol, nalbuphine, pentazocine) Early labor/prodrome Morphine Fentanyl micrograms every mins Maintain daily maintenance of methadone or buprenorphine Reassure patient of plan Dividing dose to 3-4 doses every 6-8 hours may help (but additional analgesia required. If patient on methadone, do not administer buprenorphine Epidural with local anesthetic (bupivicaine) 4

5 Postpartum care Time of greatest risk for relapse Heightened pain sensitivity Meyer and colleagues noted increased pain postpartum and increased post-cesarean opioid requirement for methadone patients (2007) Pain often undertreated Monitor for postpartum depression Comprehensive care transition: Nurse home visits Addiction specialist (avoid interruption in medication) Postpartum Pain Medication Management Will require higher doses of opioids to achieve analgesia Continue methadone or buprenorphine (dividing dose may help) Multimodal pain management Non-steroidal antiinflamatory(ketorolac) Morphine PCA may help after C-birth Long acting regional morphine with NSAIDs Epidural may help with significant pelvic floor trauma Monitor for over-sedation 14 Breastfeeding Encourage breastfeeding if no HIV Avoid breastfeeding if illicit substance or heroin Minimal levels methadone buprenorphine in breastmilk Challenges due to neonatal abstinence: poor latch, newborn irritability, poor suck coordination Challenges caring for newborn at home: impatience, frustration, poor bonding, depression 5

6 Conclusion 6

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE

More information

Methadone and Pregnancy

Methadone and Pregnancy Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine

More information

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Opioid Use in Pregnant Women and Prenatal Care Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Objectives Summarize contextual and co-morbid factors observed among

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

Vermont Guidelines for Obstetric Providers

Vermont Guidelines for Obstetric Providers Vermont Guidelines for Obstetric Providers VERMONT GUIDELINES FOR OBSTETRIC PROVIDERS Overview... 1 Opioid Maintenance During Pregnancy... 1 medication and treatment setting options... 1 Methadone... 2

More information

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to

More information

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities 10/26/15 Perspec'ves on maternal opioid use and abuse Dr. Rita J. Nutt Our Expectation Harsh Realities 1 Opioid Abuse and Dependence Statistics, 2013 4.5 million people in the US current non- medical users

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction

More information

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society Pregnant Women Who Use Drugs: Stigma, Science and Society Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia

More information

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center Opioid Use Disorder- Pregnancy Principles and Myths Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center History of NAS/NOWS Prior to 1875 infants not thought to be affected Congenital Morphinism

More information

Child Welfare and MOMS: Building Partnerships to Improve Care

Child Welfare and MOMS: Building Partnerships to Improve Care Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly

More information

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016 Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute

More information

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Fear Shame Commitment Barriers Opportunities Fear Thalidomide induced phocomelia 1957 Fear Fetal Alcohol

More information

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Dale Robinson MD,FACOG Jennifer Gonzalez RN,BSN Surgeon General s Report 2016 Office

More information

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a

More information

Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance

Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical

More information

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Centers for Disease Control and Prevention Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Jenna Meyer MPH, RNC-MNN, IBCLC Public Health Advisor Therapies for Opioid Dependent

More information

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Background The American Society of Addiction Medicine (ASAM) is deeply committed

More information

Introducing the Snuggle ME Recommendations: Care of Pregnant Women with Perinatal Substance Use with a Focus on Pain Management

Introducing the Snuggle ME Recommendations: Care of Pregnant Women with Perinatal Substance Use with a Focus on Pain Management Maine Quality Counts presents Provider Lunch & Learn: Pain Management Series Introducing the Snuggle ME Recommendations: Care of Pregnant Women with Perinatal Substance Use with a Focus on Pain Management

More information

Treatment of Opioid Use Disorder in Women During Pregnancy and Postpartum

Treatment of Opioid Use Disorder in Women During Pregnancy and Postpartum Treatment of Opioid Use Disorder in Women During Pregnancy and Postpartum Leena Mittal, MD Instructor of Psychiatry, Harvard Medical School Director, Reproductive Psychiatry Consultation Service, Divisions

More information

Substance Abuse In Pregnancy. N.L. Meyer, MD University of Tennessee Health Science Center November 18, 2016

Substance Abuse In Pregnancy. N.L. Meyer, MD University of Tennessee Health Science Center November 18, 2016 Substance Abuse In Pregnancy N.L. Meyer, MD University of Tennessee Health Science Center November 18, 2016 Disclosures No Financial Relationships To Disclose Substance Use Disorders DSM - IV Abuse at

More information

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA THE OPIOID CRISIS DEFINING THE CRISIS KATHLEEN DUPPER, MD MEDICAL DIRECTOR, HUNTSVILLE RECOVERY 19 th Annual Perinatal Conference: The Opioid Crisis September 21, 2018 DEFINING THE CRISIS NUMBER OF OPIOID-RELATED

More information

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem Substance Use Disorders Pregnancy Laura Lander, MSW, LICSW, Assistant Professor Department of Behavioral Medicine and Psychiatry, WVU Celebrating Connections Conference - April 2017 Substance Use Disorders

More information

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION AND PREGNANCY L y n é e B r o w n, M A, C D P & D o n n a L i v i n g s t o n, R N A D A P T E D F R O M J i m W a l s h, M D Objectives: Recognize common fears and myths associated with substance

More information

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes

More information

Pregnancy, Opioid Addiction, and Care Issues in Virginia

Pregnancy, Opioid Addiction, and Care Issues in Virginia Pregnancy, Opioid Addiction, and Care Issues in Virginia Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia

More information

25/04/2017. Many misconceptions, and much resistance to use Patients worry about it in pregnancy

25/04/2017. Many misconceptions, and much resistance to use Patients worry about it in pregnancy Many misconceptions, and much resistance to use Patients worry about it in pregnancy Lexy Regush Opioid Substitution Conference April 30 2017 Uninformed healthcare providers (HCPs) see methadone as a marker

More information

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome 1 Learning Objectives Become familiar with how the opioid epidemic is impacting Texas women Become familiar with Neonatal

More information

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a

More information

The Substance Exposed Newborn Alphabet Soup

The Substance Exposed Newborn Alphabet Soup The Substance Exposed Newborn Alphabet Soup SEN, NAS, NOWS, OUD, SUD & MAT Sara Park MD Chief Medical Officer Comprehensive Medical and Dental Program Department of Child Safety CAP conference, July 2017

More information

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit

More information

Prenatal Substance Abuse: Improving Outcomes

Prenatal Substance Abuse: Improving Outcomes Prenatal Substance Abuse: Improving Outcomes Jennifer Yates, MSN Family Nurse Practitioner Children s Hospital of Wisconsin Child Advocacy and Protection Services Overview Discuss the Problems Health,

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3 PROJECT DOVE Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3 Partners Support Bureau of Justice Assistance, Department of Justice Grant # PM-BX-Koo4 Treatment Plan MODULE

More information

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Opioid use in pregnancy and Neonatal Abstinence Syndrome Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,

More information

THE OPIOID DEPENDENT MOTHER AND NEWBORN - AN UPDATE

THE OPIOID DEPENDENT MOTHER AND NEWBORN - AN UPDATE THE OPIOID DEPENDENT MOTHER AND NEWBORN - AN UPDATE THE 6 TH ANNUAL IVEY SYMPOSIUM Ron Abrahams, Claudette Chase, Judy Desmoulin, Mel Kahan, David Knoppert, Gideon Koren, Laura Lyons, Alice Ordean, Henry

More information

OPIOID MICRO TRAINING MODULE 4: UNDERSTANDING OPIOID USE, PREGNANCY, AND NEONATAL ABSTINENCE SYNDROME (NAS)

OPIOID MICRO TRAINING MODULE 4: UNDERSTANDING OPIOID USE, PREGNANCY, AND NEONATAL ABSTINENCE SYNDROME (NAS) OPIOID MICRO TRAINING MODULE 4: UNDERSTANDING OPIOID USE, PREGNANCY, AND NEONATAL ABSTINENCE SYNDROME (NAS) This training is offered by the Florida Alcohol and Drug Abuse Association and JBS International.

More information

Brief History of Methadone Maintenance Treatment

Brief History of Methadone Maintenance Treatment METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what

More information

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia The American Journal on Addictions, 27: 92 96, 2018 Copyright 2018 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12687 Brief Report: Treating Women

More information

Managing Unanticipated Childbirth Complications. Disclosures. Objectives 4/20/2018

Managing Unanticipated Childbirth Complications. Disclosures. Objectives 4/20/2018 Managing Unanticipated Childbirth Complications Ebony Boyce Carter, MD, MPH Maternal Fetal Medicine Washington University in St. Louis Disclosures I have no financial disclosures to report. Objectives

More information

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.32 Subject: Suboxone Drug Class Page: 1 of 7 Last Review Date: June 24, 2016 Suboxone Drug Class Description

More information

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment Postpartum Counseling for Women in MAT Katie Clark MSPH, CSAC A little about Katie SUD and PH crossroads BA Health Arts and Sciences Goddard College MSPH MCH UNC Project Lazarus, Yale, CHER Solutions LLC

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of

More information

The Social Worker s Role in Medication Assisted Treatment

The Social Worker s Role in Medication Assisted Treatment The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment

More information

Opiate Use in Reproductive Age Females

Opiate Use in Reproductive Age Females Opiate Use in Reproductive Age Females February 15, 2017 2:00 pm-3:00 pm ET In order to hear the presentation please call +1 (562) 247-8422, access code 579-542-512 All Participant Phone Lines are Muted

More information

OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS

OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS LEO O. LANOIE, MD, MPH, FCFP, CCSAM, ABAM, FISAM, MRO Dr. Leo Lanoie, 2017 DISCLAIMER In the past year I have accepted funds from Purdue for speaking OPIOID

More information

Medication for the Treatment of Addiction (MAT)

Medication for the Treatment of Addiction (MAT) Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication

More information

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC. Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC Key Issues Significant increase in number of pregnant women addicted to prescription

More information

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School

More information

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5

More information

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Beyond Birth: A Comprehensive Recovery Center serving parenting women Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description

More information

Talking with your doctor

Talking with your doctor SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD 1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits

More information

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns

More information

Opioid Use Disorder. in Pregnancy: Care and Context of Mother and Newborn

Opioid Use Disorder. in Pregnancy: Care and Context of Mother and Newborn Opioid Use Disorder in Pregnancy: Care and Context of Mother and Newborn PRESENTED BY: Mishka Terplan MD MPH FACOG FASAM Kelley Saia MD FACOG DABAM Elizabeth Krans MD MSc FACOG September, 22 2016 Medicaid

More information

Opioid Addiction and Dependence in Pregnancy

Opioid Addiction and Dependence in Pregnancy Opioid Addiction and Dependence in Pregnancy Amy Langenfeld MS, APRN, CNM, PHN, SANE-A Some of the things we will cover today... Discuss opioid addiction trends in Minnesota. Discuss the identification

More information

Opioid Abuse Treatment in Pregnancy

Opioid Abuse Treatment in Pregnancy University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Opioid Abuse Treatment in Pregnancy Catherine A. Suppan Follow this and additional works

More information

Effects of Prenatal Illicit Drug. Use on Infant and Child

Effects of Prenatal Illicit Drug. Use on Infant and Child Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this

More information

Medication-assisted opioid addiction treatments: OB/GYN

Medication-assisted opioid addiction treatments: OB/GYN 5/13/16se Medication-assisted opioid addiction treatments: OB/GYN In October 2002, the Food and Drug Administration (FDA) approved buprenorphine monotherapy product, Subutex, and a buprenorphine/naloxone

More information

Abigail Plawman, MD. Addiction Medicine Fellowship Director MultiCare East Pierce Family Medicine.

Abigail Plawman, MD. Addiction Medicine Fellowship Director MultiCare East Pierce Family Medicine. Abigail Plawman, MD Addiction Medicine Fellowship Director MultiCare East Pierce Family Medicine plawmab@multicare.org COI statement No conflicts of interest to disclose Addiction (ASAM definition) Addiction

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Referral to the Women s Alcohol and Drug Service (WADS) Procedure 1. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral is taken and processed. This includes the referral for clinical care

More information

Buprenorphine in Pregnancy: The Basics

Buprenorphine in Pregnancy: The Basics + Buprenorphine in Pregnancy: The Basics 1 Dr. Suzanne Turner & Dr. Lisa Graves Department of Family & Community Medicine St. Michael s Hospital, Toronto, ON + Mitigating Potential Bias 2 We have no financial

More information

Neonatal abstinence syndrome

Neonatal abstinence syndrome PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on the Neonatal Abstinence Syndrome. These podcasts are designed to give medical students an overview of key topics in pediatrics.

More information

POLICY and PROCEDURE

POLICY and PROCEDURE Misericordia Community Hospital Administration of Intravenous FentaNYL During Labour POLICY and PROCEDURE Labour and Delivery Manual Original Date Revised Date Approved by: Director, Women s Health, Covenant

More information

Methadone (and pregnancy care) For Women With Problematic Substance Use

Methadone (and pregnancy care) For Women With Problematic Substance Use Methadone (and pregnancy care) For Women With Problematic Substance Use George D. Carson MD FRCSC CSPQ FSOGC Director of Maternal Fetal Medicine OBJECTIVES For substance using women on methadone who are

More information

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING Opioid Use Disorder in Pregnancy 2017 Recommendations from ACOG and The Pew Charitable Trust KATHY D. HARTKE, MD, LEGISLATIVE CO-CHAIR AND IMMEDIATE PAST CHAIR, WISCONSIN SECTION OF THE AMERICAN COLLEGE

More information

Safe Babies Foster Parent Training Program

Safe Babies Foster Parent Training Program Safe Babies Foster Parent Training Program Module 1: Introduction to the Safe Babies Program 1 Begin the process of group participation Learning outcomes Understand the purpose and origins of the Safe

More information

The Substance Exposed Newborn Standards of Care

The Substance Exposed Newborn Standards of Care The Substance Exposed Newborn Standards of Care Sara Park MD Chief Medical Officer Comprehensive Medical and Dental Program Department of Child Safety CAP conference, July 2017 Disclosures I have no financial

More information

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Maternal Mental Health: Risk Factors, Ramifications, and Roles Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Disclosures None Objectives for Today Review major maternal

More information

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required Effective Date 12/13/16 Neonatal Abstinence Syndrome (NAS) Date Approved 12/13/16 Guideline Pharmacologic Protocol Supersedes Date None and Management Guidelines Originating Dept. NICU Document Owner Dir.,

More information

Methadone Maintenance 101

Methadone Maintenance 101 Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms

More information

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome? Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute

More information

Methadone (and pregnancy care) For Women With Problematic Substance Use

Methadone (and pregnancy care) For Women With Problematic Substance Use Methadone (and pregnancy care) For Women With Problematic Substance Use George D. Carson MD FRCSC CSPQ FSOGC Director of Maternal Fetal Medicine Regina Qu Appelle Health Region OBJECTIVES For substance

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

Drugs cross the placenta producing a new set of pharmacokinetics.

Drugs cross the placenta producing a new set of pharmacokinetics. SUBSTANCE ABUSE IN PREGNANCY Aidan Foy Director, Alcohol and Drug Services, Newcastle Mater Misericordiae Hospital Introduction Substances used in pregnancy can interfere with the success of the pregnancy

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet Now available SUBOXONE Once-daily dosing1 12 mg and 16 mg tablets A maintenance dose of SUBOXONE 12-16 mg once daily is clinically effective for most patients*1 Effective maintenance dosing with SUBOXONE

More information

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018 Consequences and Treatment of Opioid Abuse During Pregnancy Katie Ellis, PharmD March 12, 2018 Disclosure I have nothing to disclose. Objectives At the completion of this activity, the pharmacist will

More information

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare

More information

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone.

201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone. 201 KAR 9:270. Professional standards for prescribing or dispensing Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone. RELATES TO: KRS 311.530-311.620, 311.990 STATUTORY AUTHORITY: KRS

More information

Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS)

Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS) University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2014 Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS) Michael

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

Substance Use Disorders in High Risk Pregnancy

Substance Use Disorders in High Risk Pregnancy Substance Use Disorders in High Risk Pregnancy OBJECTIVE The objective of this Clinical Practice Guideline (CPG) is to provide evidence-based practice recommendations for the treatment of substance use

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

The Substance Exposed Newborn Alphabet Soup

The Substance Exposed Newborn Alphabet Soup The Substance Exposed Newborn Alphabet Soup SEN, NAS, NOWS, OUD, SUD & MAT Sara Park MD Chief Medical Officer Comprehensive Medical and Dental Program Department of Child Safety CAP conference, July 2017

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

EI Leadership April 24, 2018

EI Leadership April 24, 2018 Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families

More information

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center NSDUH, 2012 National Survey on Drug Use and Health: 2012 Substance abuse: Public Health Problem

More information

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Referral to the Women s Alcohol and Drug Service (WADS) Procedure Procedure Referral to the Women s Alcohol and Drug Service (WADS) Procedure. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral

More information